Comparative Analysis of rAAV Production from Plasmid-Encoded Versus Chromosomally Integrated rAAV Transgene in HEK293 Cells
Open Access
- 18 June 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (12) , 5538
Abstract
Stable cell lines have recently achieved recombinant adeno-associated virus (rAAV) titers comparable to the standard triple transfection approach, making them a promising alternative to plasmid-based production systems. However, whether integration of the rAAV transgene into the host genome influences packaging efficiency and vector quality remains unclear. In this study, we generated stable HEK293 cell lines carrying the rAAV transgene in their genome. rAAV production was enabled by supplying the rep/cap and helper genes on two plasmids, rendering vector genome generation dependent on the chromosomally integrated transgene. Although the stable cell lines produced a 4.5-fold lower titer of viral genomes (VGs) compared to the standard triple transfection method, VG-normalized potency was four times higher. Detailed particle characterization further revealed 3-fold lower plasmid backbone DNA packaging in rAAVs produced by stable cell lines relative to triple transfection. Consistent results were obtained from mass photometry and ELISA/ddPCR analyses for the double transfection condition, while discrepancies emerged under triple transfection. These findings emphasize the importance of functional and qualitative assessments for evaluating different rAAV production approaches.Keywords
Funding Information
- Austrian Federal Ministry of Labour and Economy
- Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
- Christian Doppler Forschungsgesellschaft
- Boehringer Ingelheim International
- BOKU Doctoral School Bioprocess Engineering
This publication has 59 references indexed in Scilit:
- Comparative Analysis of HEK293 Genomic VariabilityBiotechnology and Bioengineering, 2025
- Perfusion‐Based Production of rAAV via an Intensified Transient Transfection ProcessBiotechnology and Bioengineering, 2025
- A synthetic platform for developing recombinant adeno‐associated virus type 8 producer cell linesBiotechnology Progress, 2025
- High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditionsBiotechnology Progress, 2024
- Only a small fraction of cells produce assembled capsids during transfection‐based manufacturing of adeno‐associated virus vectorsBiotechnology and Bioengineering, 2022
- Separating Empty and Full Recombinant Adeno‐Associated Virus Particles Using Isocratic Anion Exchange ChromatographyBiotechnology Journal, 2020
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular DystrophyJAMA Neurology, 2020
- Onasemnogene Abeparvovec: First Global ApprovalDrugs, 2019
- Rational plasmid design and bioprocess optimization to enhance recombinant adeno‐associated virus (AAV) productivity in mammalian cellsBiotechnology Journal, 2015
- Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell linesBiotechnology Journal, 2015